Abstract
Purpose: Many osteoarthritis (OA) patients show significant synovial involvement. Recently, we found strong upregulation of canonical Wnts 2b and 16 and Wnt-1 induced signaling protein 1 (WISP1), a downstream protein, in the synovium in two murine OA models. Wnt signaling has been implicated in OA through activation of the β-catenin pathway. In addition, TGF-β signaling is critical in cartilage maintenance. TGF-β signals via both ALK5 and ALK1 and downstream via Smad 2/3 and Smad 1/5/8 respectively. In the present study we investigated the potential of canonical Wnts to skew TGF-β signaling from the protective Smad 2/3 pathway towards the Smad 1/5/8 pathway, which can induce chondrocyte hypertrophy. Methods: Pathway analysis of microarray data from the synovium of a collagenase-induced OA (CIOA) mouse model was done using DAVID software. In vivo synovial overexpression of genes from the canonical Wnt signaling pathway was achieved by intra-articular injection of adenoviral vectors. Gene expression was analyzed by qPCR after overexpression of Wnt genes in human chondrocytes. Detection of Smad 2/3 and Smad 1/5/8 phosphorylation was done by Western blot analysis. Functional TGF-β signaling via ALK5 was measured using the luciferase reporter construct CAGA-Luc. Results: Pathway analysis using DAVID, showed that both the Wnt and TGF-β signaling pathway were enriched in the synovium of mice with CIOA. Because of their relatively small size, Wnts and WISP1 proteins can migrate into the cartilage and possibly alter chondrocyte phenotype. To determine if synovial overexpression of canonical Wnts leads to Wnt signaling in the cartilage, we injected adenoviral vectors for Wnt8a and Wnt16 into murine knee joints. These vectors specifically target synovial cells, because due to their size they cannot enter the cartilage. Synovial overexpression of Wnt8a and Wnt16 led to β-catenin accumulation in chondrocytes, a tell-tale sign of canonical Wnt signaling. In vitro overexpression of canonical Wnts and WISP1 in human chondrocytes led to significantly increased collagen type X and significantly decreased type II collagen expression, suggesting a loss of chondrocyte phenotype. Moreover, pre-incubation with Wnt3a and/or WISP1 resulted in decreased TGF-β-induced phosphorylation of Smad 2/3, whereas phosphorylation of Smad 1/5/8 was increased in both murine and human chondrocytes. This implies a shift towards dominant TGF-β signaling via the hypertrophy-inducing ALK1 pathway. On a functional level, pre-incubation with Wnt3a and/or WISP1 led to decreased CAGA-Luc reporter construct activity, confirming decreased ALK5 signaling. Moreover, the expression of the anti-hypertrophic factor Sox9 was decreased after pre-incubation with Wnt3a and WISP1. In order to investigate whether Wnt3a skews the TGF-β signaling via the canonical signaling pathway, we pre-incubated chondrocytes with Wnt3a and/or WISP1 in the presence of DKK-1, a selective inhibitor of the canonical Wnt signaling pathway. Compared to the groups without DKK-1, we found increased Smad 2/3 phosphorylation and decreased phosphorylation of Smad 1/5/8 after Wnt3a stimulation. Conclusions: Wnts produced in the synovium may play an important role in OA pathology by changing the chondrocyte phenotype, probably through modulation of the important TGF-β signaling pathway via the canonical Wnt signaling pathway. This points towards Wnt/WISP1 expression in the synovium as an interesting target for OA therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.